Biocatalytic access to hydroxylated products
Product Description
Enzyan Biocatalysis GmbH
-
Country/Region:Austria
-
On CPHI since:2022
-
Employees:1 - 24
Company types
Primary activities
Enzyan Biocatalysis GmbH
-
Country/Region:Austria
-
On CPHI since:2022
-
Employees:1 - 24
Company types
Primary activities
More Products from Enzyan Biocatalysis GmbH (2)
-
Product Biocatalytic access to chiral amines
We have a large panel of imine reductases (>140). These enzymes have a large substrate scope catalysing the enantioselective synthesis of chiral amines. We offer access to our panel to customers interested in exploring this chemistry. -
Product Biocatalytic cascade to DMT derivatives
We developed and patented a combination of enzymes to access N,N-dimethyltryptamine and its derivatives (5-MeO DMT, psilocybin, psilocin, triptans). We look for strategic partnerships to advance the development of this bioprocess.

